• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Canada
  • United Kingdom
  • Subscribe
  • facebook
  • instagram
  • RSS
  • RSMUS.com

The Real Economy Blog

Search

  • Economics
  • Technology
  • Consumer
  • Industrials
  • Finance
  • Real Estate
  • Health Care
  • Life Sciences
Home > Coronavirus > CHART OF THE DAY: Business development companies show continued risk

CHART OF THE DAY: Business development companies show continued risk

Oct. 9, 2020 by Kennedy Chinyamutangira

  • email
  • Twitter
  • Facebook
  • Linkedin

Business development companies are still lagging the market in a sign of persisting concern over the performance of loans to small and midsize businesses. Although default rates and losses in BDC loan portfolios have not been as dire as initially expected during the depth of the market panic in March, BDCs have struggled to recover, even as the broader market has rebounded.

Liquidity injections by BDCs, loan modifications, the reopening of the economy and government funding programs have helped to sustain cash flows and stave off defaults by small to midsize businesses. Yet the risk of default rates rising remains elevated as long as the economy is not out of the woods. The potential threat of a second wave of the pandemic also looms large.

For more information on how the coronavirus is affecting midsize businesses, please visit the RSM Coronavirus Resource Center.

  • email
  • Twitter
  • Facebook
  • Linkedin

Related posts

  • SEC gives regulatory relief to certain business development companies

    Continuing a recent push to ease regulations, the Securities and Exchange Commission recently adopted a final rule that loosens compliance requirements on business development companies, which invest in small and medium-size businesses.

  • How business development companies can weather the coronavirus downturn

    The stock prices of business development companies, which invest in small and midsize companies along with distressed enterprises, have experienced the sharpest and fastest decline since the financial crisis of 2008-9. Still, BDCs may ultimately have a better…

  • How business development companies are navigating the economic shock

    As business development companies reel from the effects of the coronavirus outbreak, the valuations of their portfolio companies have dropped as the risk of default has grown amid a liquidity crunch. But there are steps they can take…

Filed Under: Coronavirus, Financial Services Tagged With: BDCs, business development companies, coronavirus, Covid-19

About Kennedy Chinyamutangira

In May 2019, Kennedy Chinyamutangira was selected as a senior analyst in RSM’s cutting-edge Industry Eminence Program. The program positions its participants to understand, forecast and communicate economic, business and technology trends shaping the industries RSM serves. Kennedy’s focus is on the financial services industry.

Primary Sidebar

Other Regions

  • Canada
  • United Kingdom

Categories

  • Economics
  • Technology
  • Consumer Products
  • Industrials
  • Financial Services
  • Real Estate
  • Health Care
  • Life Sciences

Recent Finance articles

CHART OF THE DAY: Institutional investors warm to digital assets

Jan. 25, 2021

CHART OF THE DAY: The SPAC boom accelerates

Jan. 20, 2021

5 trends from defense technology companies’ Q3 earnings calls

Jan. 4, 2021

RSMUS.com links

The Real Economy

Middle Market Business Index

MMBI Special Reports

Footer

  • Facebook
  • Instagram
  • RSS

About The Real Economy Blog

The Real Economy Blog from RSM US LLP was developed to provide timely economic insights about the middle market economy. It is offered as a complement to RSM’s macroeconomic thought leadership, including The Real Economy monthly publication and the proprietary RSM US Middle Market Business Index (MMBI).

© 2021 RSMUS.com | Privacy Policy | Cookie Policy

The Real Economy Blog
  • Economics
  • Technology
  • Consumer
  • Industrials
  • Finance
  • Real Estate
  • Health Care
  • Life Sciences